• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促进和阻碍社区药剂师进行仿制药替代和参考定价系统咨询的因素——对芬兰药剂师的调查。

Factors facilitating and hindering counselling about generic substitution and a reference price system in community pharmacies - a survey among Finnish dispensers.

机构信息

School of Pharmacy, Social Pharmacy, Faculty of Health Sciences, Kuopio Campus, University of Eastern Finland, PO Box 1627, FI-70211, Kuopio, Finland.

出版信息

BMC Health Serv Res. 2022 Sep 7;22(1):1130. doi: 10.1186/s12913-022-08477-2.

DOI:10.1186/s12913-022-08477-2
PMID:36071413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9454142/
Abstract

BACKGROUND

Pharmacies play the key role in implementing generic substitution (GS) and counselling customers about it. This study aimed to explore dispensers' perceptions of the factors that facilitate or hinder counselling customers on GS and the reference price system (RPS) in community pharmacies. It also studied dispensers' opinions about the benefits and problems of these systems and discusses them from the counselling point of view.

METHODS

A postal survey was conducted among Finnish community pharmacy dispensers in spring 2018. The research questions were studied through open-ended questions and analyzed both qualitatively and quantitatively. The questions were analyzed first with inductive content analysis by two researchers independently. The responses were encoded and categorized according to the analytical framework, which was inductively developed alongside the analysis. The categorized responses were further analyzed using frequencies and percentages.

RESULTS

The response rate was 50.8% (n = 498). Of the respondents, 75.9% reported factors that facilitated counselling about GS and RPS. The most commonly mentioned factors included customers' characteristics (36.5%), the information systems used in the pharmacy (28.3%), and the features of interchangeable medicines (21.7%). Of the respondents, 89.0% reported factors that hindered counselling, of which customers' characteristics (45.8%), the unavailability of medicines and other availability issues (32.5%), the features of interchangeable medicines (22.6%) and time pressure in the pharmacy (22.1%) were the most commonly reported. The benefits of the systems focused on cost savings for customers and society (74.4%). The most commonly reported problems concerned medicine availability (31.9%), changes in medicine prices and in reference price band (28.9%), as well as how GS is time-consuming and increases workload (24.2%).

CONCLUSIONS

Finnish dispensers reported more hindering than facilitating factors in GS and RPS counselling. Customers' characteristics were the most often mentioned in both cases. Customers' knowledge could be increased by providing information and education. However, developing simpler regulations for GS and RPS, intelligent assisting software, and solutions for secured medicine availability would facilitate implementation of GS. Simplified price counselling would also guarantee the time needed and focus on instructions on the correct and safe use of medicines.

摘要

背景

药店在实施仿制药替代(GS)和向顾客提供相关咨询方面发挥着关键作用。本研究旨在探讨药剂师对促进或阻碍社区药店向顾客提供 GS 和参考定价系统(RPS)咨询的因素的看法,以及他们对这些系统的益处和问题的看法,并从咨询的角度对其进行讨论。

方法

2018 年春季,对芬兰社区药房药剂师进行了邮寄调查。通过开放式问题研究了研究问题,并进行了定性和定量分析。两位研究人员首先对问题进行了独立的归纳内容分析。根据分析框架对回复进行编码和分类,该分析框架是在分析过程中逐步提出的。进一步使用频率和百分比对分类回复进行分析。

结果

回复率为 50.8%(n=498)。在回答者中,75.9%报告了促进 GS 和 RPS 咨询的因素。最常提到的因素包括顾客特征(36.5%)、药店使用的信息系统(28.3%)和可互换药品的特征(21.7%)。在回答者中,89.0%报告了阻碍咨询的因素,其中顾客特征(45.8%)、药品不可用和其他可用性问题(32.5%)、可互换药品的特征(22.6%)和药店的时间压力(22.1%)是最常提到的。该系统的益处主要集中在为顾客和社会节省成本上(74.4%)。最常报告的问题涉及药品供应(31.9%)、药品价格和参考价格带的变化(28.9%),以及 GS 耗时且增加工作量(24.2%)。

结论

芬兰药剂师在 GS 和 RPS 咨询方面报告的阻碍因素多于促进因素。在这两种情况下,顾客特征都是最常被提及的。通过提供信息和教育,可以提高顾客的知识水平。然而,简化 GS 和 RPS 的法规、智能辅助软件以及确保药品供应安全的解决方案,将有助于实施 GS。简化价格咨询还将确保有足够的时间,并注重正确和安全使用药品的指导。

相似文献

1
Factors facilitating and hindering counselling about generic substitution and a reference price system in community pharmacies - a survey among Finnish dispensers.促进和阻碍社区药剂师进行仿制药替代和参考定价系统咨询的因素——对芬兰药剂师的调查。
BMC Health Serv Res. 2022 Sep 7;22(1):1130. doi: 10.1186/s12913-022-08477-2.
2
The content of patient counseling about interchangeable medicines and generic substitution in Finnish community pharmacies - a survey of dispensers.芬兰社区药店中关于可互换药品和仿制药替代的患者咨询内容 - 药剂师的调查。
BMC Health Serv Res. 2019 Dec 11;19(1):956. doi: 10.1186/s12913-019-4798-2.
3
Reasons for allowing and refusing generic substitution and factors determining the choice of an interchangeable prescription medicine: a survey among pharmacy customers in Finland.允许和拒绝仿制药替代的原因以及决定选择可互换处方药的因素:芬兰药剂师顾客调查。
BMC Health Serv Res. 2020 Feb 3;20(1):82. doi: 10.1186/s12913-020-4894-3.
4
Benefits, Problems, and Potential Improvements in a Nationwide Patient Portal: Cross-sectional Survey of Pharmacy Customers' Experiences.全国性患者门户的优势、问题及潜在改进:药剂顾客体验的横断面调查。
J Med Internet Res. 2021 Nov 3;23(11):e31483. doi: 10.2196/31483.
5
Pharmacy Customers' Experiences With Electronic Prescriptions: Cross-Sectional Survey on Nationwide Implementation in Finland.药房顾客使用电子处方的体验:芬兰全国范围内实施情况的横断面调查
J Med Internet Res. 2018 Feb 23;20(2):e68. doi: 10.2196/jmir.9367.
6
The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland.仿制药替代对制药公司活动的影响——从公司角度对芬兰引入仿制药替代一年及五年后的调查。
BMC Clin Pharmacol. 2010 Oct 22;10:15. doi: 10.1186/1472-6904-10-15.
7
Counselling with a focus on product and price transparency for over-the-counter headache medicines: A simulated patient study in community pharmacies in Munich, Germany.以产品和价格透明度为重点的头痛药非处方柜台咨询:德国慕尼黑社区药房的模拟患者研究。
Int J Health Plann Manage. 2024 Sep;39(5):1434-1455. doi: 10.1002/hpm.3817. Epub 2024 Jun 24.
8
Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland.芬兰第一年期间客户和医生对非专利药品替代的看法及体验
Health Policy. 2007 Aug;82(3):366-74. doi: 10.1016/j.healthpol.2006.10.006. Epub 2006 Dec 1.
9
Customers' information seeking behavior prior to community pharmacy visits: A community pharmacy survey.顾客在前往社区药店就诊前的信息寻求行为:一项社区药店调查。
Res Social Adm Pharm. 2020 Oct;16(10):1442-1446. doi: 10.1016/j.sapharm.2019.12.021. Epub 2019 Dec 26.
10
Experiences and perceptions of foreign-language customers on medication information received in the pharmacy - a focus group study.外籍顾客在药房获得药物信息的体验和看法——一项焦点小组研究。
Int J Pharm Pract. 2021 Aug 11;29(4):330-335. doi: 10.1093/ijpp/riab021.

引用本文的文献

1
The Role of Pharmacists in Counteracting Vaccine Hesitancy: Effectiveness of the 2019 Carnia Project in Improving Adherence to Influenza Vaccination among Target Population.药剂师在应对疫苗犹豫方面的作用:2019年卡尔尼亚项目在提高目标人群流感疫苗接种依从性方面的有效性。
Vaccines (Basel). 2024 Mar 20;12(3):331. doi: 10.3390/vaccines12030331.

本文引用的文献

1
Knowledge, perceptions and practices of pharmacists regarding generic substitution in China: a cross-sectional study.中国药师对药品通用名替换的知识、看法和实践:一项横断面研究。
BMJ Open. 2021 Oct 18;11(10):e051277. doi: 10.1136/bmjopen-2021-051277.
2
Factors influencing patient participation in medication counseling at the community pharmacy: A systematic review.影响患者在社区药店参与药物咨询的因素:系统评价。
Res Social Adm Pharm. 2021 Nov;17(11):1863-1876. doi: 10.1016/j.sapharm.2021.03.005. Epub 2021 Mar 16.
3
Reasons for allowing and refusing generic substitution and factors determining the choice of an interchangeable prescription medicine: a survey among pharmacy customers in Finland.允许和拒绝仿制药替代的原因以及决定选择可互换处方药的因素:芬兰药剂师顾客调查。
BMC Health Serv Res. 2020 Feb 3;20(1):82. doi: 10.1186/s12913-020-4894-3.
4
The content of patient counseling about interchangeable medicines and generic substitution in Finnish community pharmacies - a survey of dispensers.芬兰社区药店中关于可互换药品和仿制药替代的患者咨询内容 - 药剂师的调查。
BMC Health Serv Res. 2019 Dec 11;19(1):956. doi: 10.1186/s12913-019-4798-2.
5
Swedish patients' trust in the bioequivalence of interchangeable generics. What factors are important for low trust?瑞典患者对可互换通用名药物生物等效性的信任。哪些因素对低信任度至关重要?
Pharm Pract (Granada). 2018 Oct-Dec;16(4):1298. doi: 10.18549/PharmPract.2018.04.1298. Epub 2018 Dec 14.
6
Use of generic medicines in Latvia: awareness, opinions and experiences of the population.拉脱维亚通用药品的使用:民众的认知、看法及经历
J Pharm Policy Pract. 2019 Jan 6;12:1. doi: 10.1186/s40545-018-0159-5. eCollection 2019.
7
Dispensing of Prescribed Medicines in Swiss Community Pharmacies-Observed Counselling Activities.瑞士社区药房的处方药配药——观察到的咨询活动
Pharmacy (Basel). 2018 Dec 21;7(1):1. doi: 10.3390/pharmacy7010001.
8
Exploring the prevalence of and factors associated with advice on prescription medicines: A survey of community pharmacies in an English city.探索处方药建议的普及率及相关因素:对英国一个城市社区药房的调查
Health Soc Care Community. 2017 Nov;25(6):1774-1786. doi: 10.1111/hsc.12451. Epub 2017 May 9.
9
The impact of electronic prescriptions on medication safety in Finnish community pharmacies: A survey of pharmacists.电子处方对芬兰社区药房用药安全的影响:药剂师调查
Int J Med Inform. 2017 Apr;100:56-62. doi: 10.1016/j.ijmedinf.2017.01.014. Epub 2017 Jan 20.
10
Evaluating community pharmacists' perspectives and practices concerning generic medicines substitution in Saudi Arabia: A cross-sectional study.评估沙特阿拉伯社区药剂师对通用名药物替代的看法和做法:一项横断面研究。
Health Policy. 2016 Dec;120(12):1412-1419. doi: 10.1016/j.healthpol.2016.09.018. Epub 2016 Oct 11.